What is Abatacept?
Category: Prescription Drugs
Most popular types: Orencia
Abatacept is an injectable product typically used for the treatment of moderately to severely-active rheumatoid arthritis and juvenile idiopathic arthritis.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Rheumatoid arthritis | 1710 | 84 | |
| Systemic lupus erythematosus | 13 | 5 | |
| Psoriatic arthritis | 5 | 3 | |
| Behcet's disease | 1 | 1 | |
| Chronic inflammatory demyelinating polyneuropathy | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 15 | |
| Moderate | 13 | |
| Mild | 18 | |
| None | 49 |
Commonly reported side effects and conditions associated with Abatacept
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 7 | |
| Headaches | 6 | |
| Fatigue | 3 | |
| Migraine headaches | 3 | |
| Chronic fatigue | 2 | |
| Diarrhea | 2 |
Why patients stopped taking Abatacept
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 41 | |
| Doctor's advice | 19 | |
| Side effects too severe | 14 | |
| Other | 6 | |
| Change in health plan coverage | 3 | |
| Expense | 2 | |
| Course of treatment ended | 1 | |
| Personal research | 1 |
Duration
Stopped taking Abatacept
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 10 | |
| 1 - 6 months | 12 | |
| 6 months - 1 year | 21 | |
| 1 - 2 years | 6 | |
| 2 - 5 years | 8 | |
| 5 - 10 years | 1 |
What people switch to and from
Patients started taking Abatacept after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Adalimumab (Humira) | 18 | |
| Infliximab (Remicade) | 12 | |
| Tocilizumab (Actemra) | 10 | |
| Methotrexate (Apo-Methotrexate) | 9 | |
| Certolizumab (Cimzia) | 8 |
Patients stopped taking Abatacept and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Tocilizumab (Actemra) | 11 | |
| Rituximab (Rituxan) | 10 | |
| Etanercept (Enbrel) | 4 | |
| Infliximab (Remicade) | 4 | |
| Tofacitinib (Xeljanz) | 4 |
Last updated: